long term effects of glp-1 Adverse class drugs. Gastrointestinal issues are New Research on GLP-1s &
Description
E.Koch-LaskowskiK.KrawczykJ.ReinerD
Billing occurs every 28 days or monthly depending on the specific program
GLP-1 receptor agonists are drugs that mimic the action of our naturally occurring hormone, Glucagon-like peptide-1 (GLP-1)
Methods GLP-1 agonists included in the analysis were approved for treatment of obesity (Saxenda, Wegovy, Zepbound) and corresponding formulations that may potentially be used off-label for treatment of obesity (Mounjaro, Ozempic, Rybelsus, Victoza)
Korner, M., Waser, B
